Health

Vollständige Daten zur Dosiseskalation zeigen anhaltend hohe Ansprechraten und ein günstiges Sicherheitsprofil von ISB 2001, einem ersten trispezifischen Antikörper gegen BCMA × CD38 × CD3, zur Behandlung von rezidiviertem/refraktärem multiplem Myelom
Implantica announces that UK NICE has published positive recommendations for the RefluxStop™ procedure in the NHS public hospitals
Police investigate heart deaths at NHS hospital
Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
CareOregon and Health Share of Oregon Notify Members of Privacy Incident
CareOregon Notifies Members of Privacy Incident
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics
Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints
BioVaxys Issues Corporate Update
RxWellness Spine & Health Acquires AllCare Chiropractic & Injury, Expands Multi-Regional Footprint with Four New Maryland Clinics
Sechstes globales Pharmaunternehmen wählt LifeSphere NavaX für GenAI-gesteuerte Fallbearbeitung
La sixième société pharmaceutique mondiale choisit LifeSphere NavaX pour le traitement des cas basé sur l'IA générative
Essential Thrombocythemia Market to Witness Robust Growth During the Forecast Period (2025-2034) Amid Rising R&D Activity | DelveInsight
Tixel i® Demonstrates Sustained Improvements in Dry Eye Symptoms
National Association for Healthcare Quality® Proves a Financial Return to Investing in Quality
Walnut Hill Study Exposes Systemic Medicare Advantage Barriers Causing Delays, Denials, and Patient Abandonment
Join Pet Partners' World's Largest Pet Walk to Support Therapy Animal Teams Worldwide
Jim Belushi Launches Belushi's Farm Signature Strains at Bloom Cannabis Dispensaries
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information